France creates committee to draft rules for medical cannabis trial
The French Agency for the Safety of Medicines and Health Products (ANSM) created a scientific committee to write certain rules ahead of the launch of a two-year medical cannabis experiment. The areas of focus of the committee will be: The products that will become available to patients during the trial. The training ofContinue Reading